NFL BIOSCIENCES (EPA:ALNFL) | WebDisclosure

Basculer en Français

8271	Companies
113705	Keywords
54631	Articles
62043	Press releases

Home
Companies
NFL BIOSCIENCES

BRIEF

published on 11/18/2024 at 17:50, 3 hours 57 minutes ago

NFL Biosciences Presents NFL-101 at Tobacco Congress

NFL Biosciences Smoking Cessation NFL-101 Tobaccology Disruptive Mechanism
BRIEF

published on 11/18/2024 at 17:50, 3 hours 57 minutes ago

NFL Biosciences présente NFL-101 au congrès de tabacologie

NFL Biosciences NFL-101 Sevrage Tabagique Tabacologie Mécanisme Disruptif
REGULATED PRESS RELEASE

published on 11/18/2024 at 17:45, 4 hours 2 minutes ago

NFL BIOSCIENCES : LE MÉCANISME D’ACTION NOUVEAU ET DISRUPTIF DE NFL-101 POUR LE SEVRAGE TABAGIQUE PRÉSENTÉ AU CONGRÈS ANNUEL DE LA SOCIÉTÉ FRANCOPHONE DE TABACOLOGIE
Restrictions on publication in the US, UK, Canada, Australia, and Japan

Canada UK Publication US Restrictions
REGULATED PRESS RELEASE

published on 10/18/2024 at 08:00, 1 month ago

NFL BIOSCIENCES: LEADERSHIP TEAM PREPARING THE NEXT STAGES IN ITS DEVELOPMENT
REGULATED PRESS RELEASE

published on 10/18/2024 at 08:00, 1 month ago

NFL BIOSCIENCES : L’ÉQUIPE DIRIGEANTE PRÉPARE LES PROCHAINES ÉTAPES DU DÉVELOPPEMENT
REGULATED PRESS RELEASE

published on 10/08/2024 at 08:00, 1 month 10 days ago

NFL BIOSCIENCES : VALIDATION DE L’EFFICACITÉ PAR DES ANALYSES ACTUALISÉES DE CESTO II EN SEVRAGE TABAGIQUE. RÉDUCTION SIGNIFICATIVE DU CRAVING. FORT POTENTIEL COMMERCIAL CONFIRMÉ.
REGULATED PRESS RELEASE

published on 10/08/2024 at 08:00, 1 month 10 days ago

NFL BIOSCIENCES: EFFICACY VALIDATED THROUGH UPDATED ANALYSES FROM CESTO II FOR SMOKING CESSATION. SIGNIFICANT REDUCTION IN CRAVING. STRONG COMMERCIAL POTENTIAL CONFIRMED.
BRIEF

published on 09/27/2024 at 17:50, 1 month 21 days ago

NFL BIOSCIENCES: 2024 First-Half Business and Earnings Update

Capital Increase NFL-101 Phase 3 Trial NFL-301 Clinical Developments
BRIEF

published on 09/27/2024 at 17:50, 1 month 21 days ago

NFL Biosciences : Activités et résultats du 1er semestre 2024

Résultats Financiers NFL Biosciences NFL-101 Sevrage Tabagique Candidat Médicament
REGULATED PRESS RELEASE

published on 09/27/2024 at 17:45, 1 month 21 days ago

NFL BIOSCIENCES : ACTIVITÉS & RÉSULTATS DU 1er SEMESTRE 2024
NFL Biosciences présente ses avancées dans le développement de médicaments pour le sevrage tabagique et la réduction de la consommation d’alcool, ainsi que ses résultats financiers du 1er semestre 2024

Résultats Financiers NFL Biosciences Sevrage Tabagique Médicaments Alcool

1 2 ... 6

Accesswire

Published on 11/18/2024 at 19:00, 2 hours 47 minutes ago

8th 'Gratitude: Nanking Safety Zone' Int’l Peace Hiking Kicks Off in E.China Nanjing City
Published on 11/18/2024 at 18:30, 3 hours 17 minutes ago

Signs First Data Centre Customer for Gas-To-Power Supply
Published on 11/18/2024 at 18:30, 3 hours 17 minutes ago

Signal Gold Completes Mailing of Proxy Materials for Upcoming Shareholder Meeting
Published on 11/18/2024 at 18:00, 3 hours 47 minutes ago

Cleveland Golf Introduces HiBore XL Drivers: A Modern Take on an Iconic Design
Published on 11/18/2024 at 16:55, 4 hours 52 minutes ago

Leadership Evolution Announced by EW Healthcare Partners

View all ACCESSWIRE

EQS Group

Published on 11/18/2024 at 20:12, 1 hour 34 minutes ago

EQS-Adhoc: aap Implantate AG: EBITDA guidance raised
Published on 11/18/2024 at 20:04, 1 hour 42 minutes ago

Further postponement of the publication of the 2023 annual financial statements
Published on 11/18/2024 at 19:00, 2 hours 47 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 11 NOVEMBRE 2024 au 15 NOVEMBRE 2024
Published on 11/18/2024 at 18:54, 2 hours 53 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/18/2024 at 18:10, 3 hours 37 minutes ago

Freelance.com: 3rd quarter revenues

Les Echos

Published on 11/18/2024 at 20:00, 1 hour 47 minutes ago

Louis Hachette Group confirms its dividend policy ahead of listing on Euronext Growth (Paris)
Published on 11/18/2024 at 20:00, 1 hour 47 minutes ago

Louis Hachette Group confirme sa politique de dividende en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/18/2024 at 18:30, 3 hours 17 minutes ago

ICADE – CP - Standard & Poor’s abaisse la notation de crédit long terme du Groupe à BBB perspective stable
Published on 11/18/2024 at 18:30, 3 hours 17 minutes ago

ICADE – PR - Standard & Poor’s lowers the Group’s long-term credit rating to BBB with a stable outlook
Published on 11/18/2024 at 17:45, 4 hours 2 minutes ago

NFL BIOSCIENCES : LE MÉCANISME D’ACTION NOUVEAU ET DISRUPTIF DE NFL-101 POUR LE SEVRAGE TABAGIQUE PRÉSENTÉ AU CONGRÈS ANNUEL DE LA SOCIÉTÉ FRANCOPHONE DE TABACOLOGIE

View all LES ECHOS COMFI WIRE